Ricerca avanzata

Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2005 Settembre;17(3) > Minerva Biotecnologica 2005 Settembre;17(3):107-17

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOMINERVA BIOTECNOLOGICA

Rivista di Biologia Molecolare e Biotecnologie

Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246

Periodicità: Trimestrale

ISSN 1120-4826

Online ISSN 1827-160X

 

Minerva Biotecnologica 2005 Settembre;17(3):107-17

MEDICINAL PLANTS FOR BIOTECHNOLOGY AND BIOMEDICINE 

Oligosaccharides engineering from plants and algae applications in biotechnology and therapeutics

Delattre C., Michaud P., Courtois B., Courtois J.

Laboratory of Glucides-EPMV CNRS FRE 2779, IUT/GB, UPJV, Amiens, France

Since the last decade, newly observed functions of oligosaccharides are their ability to act as regulatory molecules on various organisms. The successful development of these compounds in future implies efficient processes for specific oligosaccharide production. For this reason, plant and algae constitute an original source of various oligosaccharidic structures. To exploit them, two strategies are available: synthesis (chemical or by enzymes) and polysaccharide cleavage (chemical, physical or biological). This review catalogues the possibilities of these methods, applied to plant and algae polysaccharide models, to generate bioactive oligosaccharides.

lingua: Inglese


Full text temporaneamente non disponibile on-line. Contattaci  ESTRATTI

inizio pagina